Bd. Shames et al., LPS-induced NF-kappa B activation and TNF-alpha release in human monocytesare protein tyrosine kinase dependent and protein kinase C independent, J SURG RES, 83(1), 1999, pp. 69-74
Background. Tumor necrosis factor alpha (TNF-alpha) is an important mediato
r of septic shock. Endotoxin (LPS) signal transduction in human monocytes l
eads to activation of nuclear factor-kappa B (NF-kappa B) and TNF-alpha rel
ease. Previous studies have implicated activation of both protein kinase C
(PKC) and protein tyrosine kinases (PTK) in LPS-induced NF-kappa B activati
on and TNF-alpha production. We hypothesized that inhibition of either PKC
or PTK would decrease LPS-induced NF-kappa B DNA binding and TNF-alpha y re
lease in human monocytes.
Materials and methods. Human monocytes were stimulated with PMA (50 ng/ml)
alone or LPS (100 ng/ ml) with and without a nonspecific serine/threonine p
rotein kinase inhibitor staurosporine (Stauro), a specific pan-PKC inhibito
r bisindolylmaleimide (Bis), or an inhibitor of PTK genistein (Gen). TNF-al
pha release in culture supernatants was measured by an ELISA. NF-kappa B DN
A binding was evaluated by electrophoretic mobility shift assay.
Results. LPS increased NF-kappa B DNA binding and TNF-alpha release in huma
n monocytes. Nonspecific protein kinase inhibition inhibited NF-kappa B act
ivation and TNF-alpha release, while specific PKC inhibition with Bis had n
o effect on LPS-induced NF-kappa B DNA binding or TNF-alpha release. PTK in
hibition with Gen attenuated both LPS-induced NF-kappa B DNA binding and TN
F-alpha production in human monocytes. Direct activation of PKC with PMA in
duced both NF-kappa B activation and TNF-alpha production by human monocyte
s.
Conclusions. These results suggest that LPS-induced NF-kappa B activation a
nd TNF-alpha release in human monocytes are independent of PKC activity, Fu
rthermore, our results provide evidence that PTK plays a role in LPS-induce
d NF-kappa B activation and TNF-alpha release in human monocytes and thus c
ould be a potential therapeutic target inflammatory states. (C) 1999 Academ
ic Press.